Cargando…
A new class of PentixaFor- and PentixaTher-based theranostic agents with enhanced CXCR4-targeting efficiency
Non-invasive PET imaging of CXCR4 expression in cancer and inflammation as well as CXCR4-targeted radioligand therapy (RLT) have recently found their way into clinical research by the development of the theranostic agents [(68)Ga]PentixaFor (cyclo(D-Tyr(1)-D-[NMe]Orn(2)(AMBS-[(68)Ga]DOTA)-Arg(3)-Nal...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Ivyspring International Publisher
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381729/ https://www.ncbi.nlm.nih.gov/pubmed/32724470 http://dx.doi.org/10.7150/thno.45537 |